CD274 and breast cancer: In the past few years, ICB has demonstrated remarkable antitumor effects in several solid tumors, especially in tumors with positive PD-L1 expression, inspiring the passion to develop ICB treatment strategies for breast cancer (Hu et al., 2017; Emens, 2018; Zhu et al., 2021b).